Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 4Prostatic Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms 3Advanced Solid Tumor 3Pancreatic Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Hypoxia 2Advanced Solid Tumors 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Pelvic Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mesothelioma 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1

Interventions

Imatinib Mesylate 11Cyclophosphamide 11Peripheral Blood Stem Cell Transplantation 9Cyclosporine 8fludarabine phosphate 7Radiotherapy 7Methotrexate 7Filgrastim 7Dasatinib 7Busulfan 7Antilymphocyte Serum 7nilotinib 6Tacrolimus 6Mycophenolic Acid 6Sirolimus 5Cord Blood Stem Cell Transplantation 5bosutinib 4Whole-Body Irradiation 4Methylprednisolone 4Melphalan 4Interferon-alpha 4ponatinib 3Alemtuzumab 3sargramostim 2Sunitinib 2Rituximab 2Moxifloxacin 2Leucovorin 2Homoharringtonine 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myeloid, Chronic-Phase × Injections × Clear all
NCT04793399 2024-03-19

Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients

Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica

Phase 1/2 Terminated
9 enrolled 7 charts
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡